Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IRIDEX Corp (NASDAQ:IRIX)

13.80
Delayed Data
As of May 23
 -0.02 / -0.14%
Today’s Change
6.42
Today|||52-Week Range
15.12
+48.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$139.1M

Company Description

IRIDEX Corp. provides therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation including laser probes, and are used in the treatment of serious eye diseases, including the three leading causes of irreversible blindness: diabetic retinopathy, glaucoma and age-related macular degeneration. IRIDEX was founded by Eduardo Arias, Theodore A. Boutacoff and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Contact Information

IRIDEX Corp.
1212 Terra Bella Avenue
Mountain View California 94043
P:(650) 940-4700
Investor Relations:

Employees

Shareholders

Other institutional46.46%
Individual stakeholders46.02%
Mutual fund holders4.97%

Top Executives

William M. MooreChairman, President & Chief Executive Officer
Ronald T. SteckelVice President-Operations
Paul H. HardimanVice President-Regulatory & Compliance
Timothy D. BuckleyVice President-Marketing & North American Sales
Stacie RodgersVice President-Human Resources